Thus, the oligomeric targeting proteins within the conjugates may, by controlling the arrangement of FGFR1 on the cell surface, upregulate internalization of the receptor-conjugate complex, improving drug delivery to the cancer cells. This evidence concerns the gene FGFR1 and cancer.